These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients. Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368 [TBL] [Abstract][Full Text] [Related]
9. Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19. Moustafa A; Khalel RS; Aziz RK OMICS; 2021 Aug; 25(8):475-483. PubMed ID: 34280038 [TBL] [Abstract][Full Text] [Related]
10. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Xiong Y; Liu Y; Cao L; Wang D; Guo M; Jiang A; Guo D; Hu W; Yang J; Tang Z; Wu H; Lin Y; Zhang M; Zhang Q; Shi M; Liu Y; Zhou Y; Lan K; Chen Y Emerg Microbes Infect; 2020 Dec; 9(1):761-770. PubMed ID: 32228226 [TBL] [Abstract][Full Text] [Related]
11. Microbiota Modulation of the Gut-Lung Axis in COVID-19. de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB Front Immunol; 2021; 12():635471. PubMed ID: 33717181 [TBL] [Abstract][Full Text] [Related]
12. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection. Mukherjee S; Banerjee B; Karasik D; Frenkel-Morgenstern M Viruses; 2021 Mar; 13(3):. PubMed ID: 33802569 [TBL] [Abstract][Full Text] [Related]
13. The lower respiratory tract microbiome of critically ill patients with COVID-19. Gaibani P; Viciani E; Bartoletti M; Lewis RE; Tonetti T; Lombardo D; Castagnetti A; Bovo F; Horna CS; Ranieri M; Viale P; Re MC; Ambretti S Sci Rep; 2021 May; 11(1):10103. PubMed ID: 33980943 [TBL] [Abstract][Full Text] [Related]
14. Interplay between SARS-CoV-2 and human long non-coding RNAs. Moazzam-Jazi M; Lanjanian H; Maleknia S; Hedayati M; Daneshpour MS J Cell Mol Med; 2021 Jun; 25(12):5823-5827. PubMed ID: 33969601 [TBL] [Abstract][Full Text] [Related]
15. Microbiota analysis optimization for human bronchoalveolar lavage fluid. Schneeberger PHH; Prescod J; Levy L; Hwang D; Martinu T; Coburn B Microbiome; 2019 Oct; 7(1):141. PubMed ID: 31665066 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets. Li Y; Duche A; Sayer MR; Roosan D; Khalafalla FG; Ostrom RS; Totonchy J; Roosan MR BMC Genomics; 2021 Feb; 22(1):125. PubMed ID: 33602138 [TBL] [Abstract][Full Text] [Related]
18. RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota. Liu T; Wu J; Han C; Gong Z; Regina G; Chen J; Dou F; Silvestri R; Chen C; Yu Z Int J Biol Sci; 2021; 17(13):3305-3319. PubMed ID: 34512148 [TBL] [Abstract][Full Text] [Related]
19. IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Zhang F; Mears JR; Shakib L; Beynor JI; Shanaj S; Korsunsky I; Nathan A; ; Donlin LT; Raychaudhuri S Genome Med; 2021 Apr; 13(1):64. PubMed ID: 33879239 [TBL] [Abstract][Full Text] [Related]
20. Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection. Cribbs SK; Uppal K; Li S; Jones DP; Huang L; Tipton L; Fitch A; Greenblatt RM; Kingsley L; Guidot DM; Ghedin E; Morris A Microbiome; 2016 Jan; 4():3. PubMed ID: 26792212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]